Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psoriasis | 4 | 2022 | 46 | 1.180 |
Why?
|
| Receptors, Somatostatin | 1 | 2021 | 7 | 0.800 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2021 | 45 | 0.790 |
Why?
|
| Scleroderma, Systemic | 2 | 2021 | 446 | 0.750 |
Why?
|
| Stevens-Johnson Syndrome | 4 | 2021 | 11 | 0.730 |
Why?
|
| Fibroblasts | 2 | 2021 | 902 | 0.700 |
Why?
|
| Caveolin 1 | 2 | 2022 | 59 | 0.680 |
Why?
|
| Monocytes | 2 | 2022 | 210 | 0.660 |
Why?
|
| Skin | 5 | 2021 | 451 | 0.420 |
Why?
|
| Interleukin-6 | 2 | 2020 | 330 | 0.300 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 49 | 0.190 |
Why?
|
| HMGB1 Protein | 1 | 2020 | 23 | 0.180 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2020 | 14 | 0.180 |
Why?
|
| Fasciitis | 1 | 2020 | 30 | 0.180 |
Why?
|
| Dermatitis, Atopic | 1 | 2020 | 17 | 0.180 |
Why?
|
| Basidiomycota | 1 | 2020 | 5 | 0.180 |
Why?
|
| Arthritis | 1 | 2020 | 53 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2022 | 204 | 0.180 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 66 | 0.170 |
Why?
|
| Mycoses | 1 | 2020 | 60 | 0.170 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2020 | 110 | 0.170 |
Why?
|
| Prednisolone | 1 | 2019 | 23 | 0.170 |
Why?
|
| Drug Eruptions | 1 | 2019 | 16 | 0.170 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2020 | 66 | 0.170 |
Why?
|
| Chemotaxis | 1 | 2019 | 38 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 82 | 0.160 |
Why?
|
| Bone Marrow Transplantation | 1 | 2019 | 149 | 0.160 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 88 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 124 | 0.150 |
Why?
|
| Doxorubicin | 1 | 2019 | 231 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2020 | 206 | 0.150 |
Why?
|
| Liver Transplantation | 1 | 2021 | 400 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2019 | 447 | 0.140 |
Why?
|
| Inflammation | 2 | 2022 | 1030 | 0.140 |
Why?
|
| Angioedema | 2 | 2019 | 41 | 0.140 |
Why?
|
| Melanoma | 1 | 2020 | 335 | 0.140 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1293 | 0.130 |
Why?
|
| Graft Rejection | 1 | 2019 | 458 | 0.130 |
Why?
|
| Humans | 13 | 2022 | 68618 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2021 | 2689 | 0.130 |
Why?
|
| Lung | 1 | 2020 | 849 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 240 | 0.120 |
Why?
|
| HIV Infections | 1 | 2020 | 791 | 0.100 |
Why?
|
| Drug Hypersensitivity | 1 | 2011 | 35 | 0.090 |
Why?
|
| Urticaria | 1 | 2011 | 84 | 0.090 |
Why?
|
| Transcriptome | 2 | 2021 | 164 | 0.080 |
Why?
|
| Japan | 2 | 2020 | 68 | 0.070 |
Why?
|
| Cytokines | 2 | 2022 | 866 | 0.070 |
Why?
|
| Mice | 1 | 2019 | 8474 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1851 | 0.060 |
Why?
|
| Middle Aged | 5 | 2020 | 21147 | 0.060 |
Why?
|
| Child | 3 | 2021 | 6405 | 0.050 |
Why?
|
| Female | 6 | 2021 | 38074 | 0.050 |
Why?
|
| Transcription Factor AP-2 | 1 | 2021 | 9 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2021 | 29 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 8912 | 0.050 |
Why?
|
| Animals | 1 | 2019 | 20881 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2021 | 111 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2020 | 14 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2022 | 343 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 56 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2020 | 3187 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2019 | 21 | 0.040 |
Why?
|
| Intertrigo | 1 | 2019 | 1 | 0.040 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 9 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 87 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 25 | 0.040 |
Why?
|
| Erythema | 1 | 2019 | 18 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 186 | 0.040 |
Why?
|
| Phenotype | 1 | 2022 | 947 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2019 | 36 | 0.040 |
Why?
|
| Blister | 1 | 2019 | 16 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2019 | 164 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2020 | 223 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2020 | 320 | 0.040 |
Why?
|
| Lymphoma | 1 | 2019 | 116 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 199 | 0.040 |
Why?
|
| Homeostasis | 1 | 2020 | 291 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 149 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2020 | 222 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 411 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 267 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2021 | 447 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 1038 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2673 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 2093 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2358 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 1026 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 4848 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 14862 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 5731 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 5717 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 21403 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 7029 | 0.020 |
Why?
|
| Male | 2 | 2020 | 37321 | 0.020 |
Why?
|